We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Adenylate Kinase Activity Controls Cystic Fibrosis Channel Protein

By Biotechdaily staff writers
Posted on 12 Feb 2004
A recent study suggests that the mechanism by which the cystic fibrosis transmembrane conductance regulator protein (CFTR) opens ion channels in lung cells is that of an adenylate kinase enzyme and not that of an ATPase as had been previously believed.

Adenylate kinase catalyzes the phosphorylation of adenosine 5'-phosphate (AMP) to adenosine 5'-disphosphate (ADP) in the presence of ATP or inorganic triphosphate in a reaction that neither requires nor releases energy. More...
This type of reaction better fits the evidence indicating that while ATP is required for CFTR channel formation, energy such as that provided by ATPase breakdown of ATP is not required for ions to flow through the channel.

Investigators at the University of Iowa (Iowa City, USA) revealed in the December 26, 2003, issue of Cell that at physiologic nucleotide concentrations, adenylate kinase activity, rather than ATPase activity, may control gating (the process by which ion channels open and close their pores) and therefore involve little energy consumption.
CFTR is a member of the ABC transporter family, the largest group of proteins that move molecules across membranes. "ABC transporter proteins contain a very conserved ‘engine' that controls transport,” explained Dr. Chrisoph Randak, a postdoctoral investigator at the University of Iowa. "Our study indicates that at least in CFTR that ‘engine' can be run either by an ATPase, which uses energy, or an adenylate kinase, which is energy-neutral.”




Related Links:
University of Iowa

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Pipette Calibration System
Artel PCS®
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.